Curative Biotechnology (CUBT) S-1 IPO registration

Exhibit 107

Calculation of Filing Fee Tables

S-1

(Form Type)

CURATIVE BIOTECHNOLOGY, INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security Type

Security Class Title(1)

Fee Calculation or Carry Forward Rule

Amount Registered

Proposed Maximum Offering Price Per Unit

Maximum Aggregate Offering Price(1)(2)

Fee Rate

Amount of Registration Fee

Carry Forward Form Type

Carry Forward File Number

Carry Forward Initial effective date

Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward

Newly Registered Securities

Fees to Be Paid

Equity

Units, each consisting of one share of Common Stock, par value $0.0001, per share and one Warrants each to purchase one share of Common Stock(1)

457(o)

1,533,332

$

6.00

$

9,199,992

$110.2 per $1,000,000

$

1,013.84

Equity

Common Stock included as part of the Units (3)(4)

457(i)

Equity

Warrants to purchase Common Stock included as part of the Units (4)(5)(6)(7)

(4)(6)

Equity

Common Stock issuable upon exercise of the Warrants (3)(7)

457(o)

1,533,332

$

9.00

$

13,799,988

$110.2 per $1,000,000

$

1,520.76

Equity

Representative’s Warrants(6)

457(g)

Equity

Common Stock issuable upon exercise of Representative’s Warrants (8)

457(g)

66,666

$

7.25

$

483,328.50

$110.2 per $1,000,000

$

53.27

Fees Previously Paid

Carry Forward Securities

Carry Forward Securities

Total Offering Amounts

$

23,483,308.50

Total Fees Previously Paid

Total Fee Offsets

Net Fee Due

$

2,587.87

(1)	Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
(2)	Includes Common Stock to cover the exercise of the over-allotment option granted to the underwriter.
(3)	Pursuant to Rule 416 of the Securities Act, the shares of common stock registered hereby also includes an indeterminable number of additional shares of common stock as may from time to time become issuable by reason of stock splits, stock dividends, recapitalizations or other similar transactions.
(4)	No fee required pursuant to Rule 457(i) under the Securities Act.
(5)	Includes Common Stock which may be issued upon exercise of additional warrants which may be issued upon exercise of the over granted to the underwriter.
(6)	In accordance with Rule 457(g) under the Securities Act, because the Common Stock underlying the Warrants are registered no registration fee is required with respect to the Warrants registered hereby.
(7)	The warrants are exercisable at a per share price of 150% of the price per Unit in this offering.
(8)	Represents Underwriter’ warrants to purchase up to the number of shares of Common Stock equal to 5% of the number of shares of Common Stock underlying Units sold in this offering, including the option to purchase over-allotments at an exercise price equal to 125% of the public offering price per Unit.